Masaya Akai
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial.
Journal: Cancer medicine
Published: January 31, 2023
Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study.
Journal: BMC pulmonary medicine
Published: January 08, 2023
Palliative surgery for malignant superior vena cava obstruction resistant to immunotherapy: a case report.
Journal: Annals of palliative medicine
Published: July 12, 2022
Xanthomatous Pleuritis Associated With Pancreaticopleural Fistula.
Journal: Journal of bronchology & interventional pulmonology
Published: September 29, 2021
Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature.
Journal: Case reports in immunology
Published: July 17, 2021
Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study.
Journal: Open forum infectious diseases
Published: February 17, 2021
Utility of Endoscopic Ultrasound with Bronchoscope-guided Fine-needle Aspiration for Detecting Driver Oncogenes in Non-small-cell Lung Cancer during Emergency Situations: Case Series.
Journal: Internal medicine (Tokyo, Japan)
Published: November 02, 2020
The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2020
Coronavirus Disease 2019 Complicated by Multiple Simultaneous Intracerebral Hemorrhages.
Journal: Internal medicine (Tokyo, Japan)
Published: September 07, 2020
Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab.
Journal: Internal medicine (Tokyo, Japan)
Published: July 31, 2020
Last Updated: 09/26/2026